NCT04463563

Brief Summary

Cerebral oximetry using near-infrared spectroscopy (NIRS) has been shown to reduce the incidence of neurological dysfunction and hospital length-of-stay in adult cardiac surgery though not all studies agree. A previous audit using cerebral saturations at or above baseline showed improved neurological and length-of-stay outcomes.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
182

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started Feb 2011

Longer than P75 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
3.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2014

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2014

Completed
5.8 years until next milestone

First Submitted

Initial submission to the registry

June 20, 2020

Completed
19 days until next milestone

First Posted

Study publicly available on registry

July 9, 2020

Completed
Last Updated

July 9, 2020

Status Verified

July 1, 2020

Enrollment Period

3.1 years

First QC Date

June 20, 2020

Last Update Submit

July 3, 2020

Conditions

Outcome Measures

Primary Outcomes (11)

  • Hospital length-of-stay

    How long before discharge post-operatively.

    Measured in days from the day of operation to the day the patient is discharged from hospital or death in hospital. If neither has occurred within 6 months of participant's operation it will be recorded as 6 months hospital stay.

  • Physical neurological examination

    Mobility and conscious control of limbs.

    3 day post-operatively

  • Neurological assessment.

    Telephone interview to assess patients perception of mobility, function and well being. (see below details)

    6 months post-operatively

  • Neurocognitive test 1

    Fluency and cognitive functions: Mini-Mental State Examination (MMSE). This test is conducted as a questionnaire of 11 questions. Questions include 'what is the date?', 'name the town you are in?', spelling-forwards and backwards, counting backwards, copying a picture, follow an instruction, naming objects etc. The test is scored out of 30 and recorded in a table. The test is repeated on the third post op day and the 2 scores compared to give a number which relates to performance.

    Day 3 post op.

  • Neurocognitive Test 2

    Visual attention and task switching: Trail Making test A and B

    Day 3 post op

  • Neurocognitive test 3

    Visual-spatial, frontal lobe: Anti-saccadic eye test

    Day 3 post op

  • Neurocognitive test 4

    Executive function/verbal immediate and delayed recall: Hopkins Verbal and Hopkins Delay.

    Day 3 post op

  • Neurocognitive test 5

    General well-being HADS (hospital anxiety and depression score) A and D. HADS A -hospital anxiety and depression score relating to Anxiety. HADS D- hospital anxiety and depression score relating to Depression. Patients are asked a question and their response is scored from 0-3. There are 14 questions the score is recorded and compared with the score after the same questions on the 3rd post-op day. The result gives an indication of the patient's mental state and how it may have changed dur to the sugery.

    Day 3 post op

  • Late neurocognitive test 1.Telephone questionnaire using elements of the previously used questionnaires.

    General health questions were: how is your overall health, memory, mood, motor function?Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.

    6 months post op

  • Late neurocognitive test 2. Telephone questionnaire using elements of the previously used questionnaires.

    Cognition questions were: Date, repeat and recall, serial 7s, spell, recall. Designed to be shorter and not require any visual skills. The questions include the patients perception of whether they believe in each domain that their performance is the same, better or worse than before the surgery.

    6 months post op

  • Late neurocognitive test 3

    Functionality questions were: Stairs, driving, cleaning, dressing, eating/cooking.

    6 months post op

Secondary Outcomes (3)

  • Intensive Care length-of-stay

    The assessment period is every day on ICU until participant moved to ward. Or patient dies on ICU. Total assessment period 6 months.

  • Major organ dysfunction

    Before hospital discharge

  • Mortality

    Day of surgery to death. If the participant is discharged from hospital alive it is not a mortality. Assessed for 6 months from the day of surgery.

Study Arms (2)

NIRS group. Brain oxygen saturations group.

ACTIVE COMPARATOR

A monitor by means of non-invasive stickers will display cerebral oximetry (brain oxygen saturations) throughout the heart surgery.This gives a direct reading of brain frontal lobe oxygen levels. The baseline is recorded before the patient goes to sleep (anaesthetised) and throughout the surgery and time on cardiopulmonary bypass if the brain oxygen levels fall below baseline then various physiological changes are made to restore oxygen to baseline.

Other: Physiological

Standard Patient Monitoring

NO INTERVENTION

No cerebral monitoring. Standard patient monitoring according to normal practice at Castle Hill Hospital apply.

Interventions

Changes to carbon dioxide, oxygen flow, cardiac output, blood pressure, haemoglobin, surgical surveillance, depth of anaesthesia, patient position.

NIRS group. Brain oxygen saturations group.

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients undergoing elective cardiac surgery using cardiopulmonary bypass. Patient over 18 years age. -

You may not qualify if:

  • Emergency surgery. Cardiac surgery without cardiopulmonary bypass. Inability to perform test.
  • Persistent neurological conditions:
  • Recent stroke. Dementia. Alzheimer's Disease Parkinson's Disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Brain Ischemia

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Sean R Bennett, MB Chb

    Consultant Anaesthetist Hull Hospital Trust

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Masking Details
The personnel assessing and collecting the post-operative data were unaware of the patient group in the operating room.
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: This prospective, single centre, double-blinded controlled study randomized 182 consecutive patients, scheduled for cardiac surgical procedures using cardiopulmonary bypass. Participants were randomized by concealed envelope.
Sponsor Type
OTHER GOV
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 20, 2020

First Posted

July 9, 2020

Study Start

February 1, 2011

Primary Completion

March 1, 2014

Study Completion

September 1, 2014

Last Updated

July 9, 2020

Record last verified: 2020-07

Data Sharing

IPD Sharing
Will not share